TrialBritish journal of clinical pharmacology2025

First-in-human safety, tolerability, pharmacokinetics and pilot food-effect study of the candidate antimalarial compound MMV367.

Andrea Kuemmerle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.